6-K ·Filed Oct 1, 2026
Notable filing: 6-K
Actionable Insight • Neutral
CFO transition at a late-stage biotech is routine; monitor upcoming earnings or pipeline updates for any strategic shift under new CFO. No immediate stock-moving catalyst.
Latest settled — T+5d
NBTX ▼ -8.04% at T+5d
NEUTRAL call -8.04% · α vs SPY -9.20% · entry $25.75 → $23.68
Latest observation: T+15 +31.60% FF3 residual α
T+1d
-2.52%
call -2.52% · α -3.20%
$25.10
settled 24d ago
T+5d
-8.04%
call -8.04% · α -9.20%
$23.68
settled 18d ago
T+20d
Pending
in 3d
T+60d
Pending
in 2mo
Price Chart
Loading chart...
Executive Summary
Nanobiotix appointed Arnd Christ as CFO effective October 1, 2026, replacing Bart Van Rhijn who stepped down after five years. Christ brings over 25 years of biotech CFO experience including at Immatics N.V. This is a routine executive transition with no financial data or guidance provided.
Key Facts
- Arnd Christ appointed CFO and executive board member effective October 1, 2026
- Christ previously served as CFO of Immatics N.V. (Oct 2020–Sep 2025) and other European biotech firms
- Bart Van Rhijn stepped down as CFO and executive board member after five years
- No financial figures, guidance, or material business updates were disclosed
Financial Impact
No financial impact disclosed
Risk Factors
- Transition risk if new CFO's strategy differs from predecessor's capital allocation approach
- No change to underlying pipeline or regulatory timelines
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001171843-26-006335 |
| Document: f6k_100126.htm | 0001171843-26-006335 |
| Document: 0001171843-26-006335-index-headers.html | 0001171843-26-006335 |
| Document: 0001171843-26-006335-index.html | 0001171843-26-006335 |
| Document: 0001171843-26-006335.txt | 0001171843-26-006335 |
25 reports for NBTX
70% Hit rate @ T+20 Went positive at some point 7 of 10 best @ T+20▲ +55.06%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | — | awaiting T+20 | — | — |
Oct 20, 2026 6d ago | 6-K | $25.83 | awaiting T+20 | — | $31.53 (+22.07%) |
Oct 1, 2026 25d ago | 6-K | $25.75 | awaiting T+20 | — | $31.53 (+22.45%) |
Oct 1, 2026 25d ago | Press Release | $25.75 | awaiting T+20 | — | $31.53 (+22.45%) |
Sep 24, 2026 4w ago | 6-K | $33.31 $29.36 | ▲ +11.86% | ▲ +10.38% | $31.53 (+5.34%) |
Sep 24, 2026 4w ago | 6-K | $33.31 $29.36 | ▼ −11.86% | ▼ −10.38% | $31.53 (−5.34%) |
Sep 24, 2026 4w ago | Press Release | $33.31 $29.36 | ▼ −11.86% | ▼ −10.38% | $31.53 (−5.34%) |
Sep 22, 2026 4w ago | Press Release | $35.24 $25.83 | ▼ −26.70% | ▼ −27.39% | $31.53 (−10.53%) |
Sep 14, 2026 6w ago | 6-K | $35.73 $23.40 | ▼ −34.51% | ▼ −36.77% | $31.53 (−11.75%) |
Jul 31, 2026 12w ago | 6-K | $38.89 $40.64 | ▲ +4.50% | ▲ +3.26% | $31.53 (−18.93%) |
Showing 10 of 25
US Market Status
Market Closed — Opens Tue (16h 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers